Cryonics in China

As of 2022, there is only one company in China who is providing cryonics services. The company is the Shandong Yinfeng Life Science Research Institute (Yinfeng), based in Jinan, Shandong, China. The company is a subdivision of Yinfeng Biology, which in turn is a division of the Yinfeng Corporation.

Yinfeng is a full service cryonics organization that provides membership, standby stabilization & transport, ECMO support, surgical and perfusion, in addition to long-term care. Their area of coverage currently is limited to mainland China and Taiwan, however they are planning on extending into all of Asia starting in 2022.

Relevant statistics: 22 employees, 6 doctors (on contract) including surgeons, anesthesiologists, and perfusionists; 1 certified foreign expert, 12 cryopreserved patients and 60+ signed-up members.

Yinfeng has a license to conduct whole-body cryopreservation within the Shandong province, under the Chinese Red Cross. For clients outside this area, ECMO is used as a bridge to transport patients from other provinces into Shandong for end-of-life care and/or immediately cryopreservation. These arrangements are in cooperation with Qi-Lu Hospital group and the Shandong Chest Hospital facilities.

ECMO, an acronym for Extra Corporeal Membrane Oxygenation, is a unique application to the cryonics industry to mitigate the potential damage that occurs to the cells, post cardiac arrest. By applying ECMO at the hospital bedside, concurrent with cardiac arrest, the donor's body can be continuously perfused with oxygenated, filtered and cooled blood, during transport up until cryoprotectant can be introduced into the patient's vascular system. This can eliminate or greatly reduce the effects of ischemic damage that occurs and is considered superior to mechanical chest compressions and ventilatory support. A team of doctors will gain vascular access, introduce venous and arterial catheters and connect to a mobile ECMO unit designed for transport in a specialized and dedicated ambulance. Upon arrival at the surgical/perfusion site, the same system can be integrated into the cryoprotectant tubing array, allowing for seamless transition from cardio/pulmonary support to blood washout and eventual perfusion.